Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aapro

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Pathologie-Biologie|January 1, 1988
Cell cultures and detection of minimal residual disease: significance and limitationsM Aapro, C Irle
British Journal of Cancer|June 27, 2002
Granisetron vs ondansetron: is it a question of duration of 5-HT3 receptor blockade?P Blower, M Aapro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
Triple-negative breast cancer in the older populationM Aapro, H Wildiers
Anti-Cancer Drugs|May 9, 2001
Docetaxel: assessing a range of activityM Aapro, E Rowinsky
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Early clinical studies with docetaxel. Docetaxel Investigators GroupM Aapro, R Bruno
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Depression in breast cancer patients: the need for treatmentM Aapro, A Cull
Hematology/Oncology Clinics of North America|February 19, 2000
Assessment of the older cancer patientM Extermann, M Aapro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2007
Cancer treatment in the elderly: the need for a better organizationS Monfardini, M Aapro
Critical Reviews in Oncology/Hematology|May 8, 1998
Breast cancerM Aapro, M Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2014
Reply to the letter to the editor 'Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer' Tannock and PondH S Rugo, M Aapro
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Pathologie-Biologie|January 1, 1988
Cell cultures and detection of minimal residual disease: significance and limitationsM Aapro, C Irle
British Journal of Cancer|June 27, 2002
Granisetron vs ondansetron: is it a question of duration of 5-HT3 receptor blockade?P Blower, M Aapro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
Triple-negative breast cancer in the older populationM Aapro, H Wildiers
Anti-Cancer Drugs|May 9, 2001
Docetaxel: assessing a range of activityM Aapro, E Rowinsky
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Early clinical studies with docetaxel. Docetaxel Investigators GroupM Aapro, R Bruno
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Depression in breast cancer patients: the need for treatmentM Aapro, A Cull
Hematology/Oncology Clinics of North America|February 19, 2000
Assessment of the older cancer patientM Extermann, M Aapro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2007
Cancer treatment in the elderly: the need for a better organizationS Monfardini, M Aapro
Critical Reviews in Oncology/Hematology|May 8, 1998
Breast cancerM Aapro, M Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2014
Reply to the letter to the editor 'Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer' Tannock and PondH S Rugo, M Aapro
Pageof 14